Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 8 Researches
7.5
USERS' SCORE
Moderately Good
Based on 5 Reviews
7.6
Supplement Facts
Serving Size: 1 Softgel
Amount Per Serving
%DV
Calories
15
Total Fat
1.5 g
2%**
Wild Caught Fish Oil Concentrate
1250 mg
†
Total Omega-3 Fatty Acids as TG
1055 mg
†
EPA (Eicosapentaenoic Acid)
690 mg
†
DHA (Docosahexaenoic Acid)
310 mg
†
Other Omega-3 Fatty Acids
55 mg
†
Top Medical Research Studies
9
Eicosapentaenoic acid alleviates back pain
We explored how eicosapentaenoic acid (EPA) might help in treating intervertebral disc degeneration (IDD), a major contributor to back pain. Research highlights that this condition often involves endoplasmic reticulum (ER) stress and breakdown of the extracellular matrix (ECM), key processes that worsen IDD. Our investigation demonstrated that EPA can promote autophagy, a process that helps cells clean up and maintain balance within the ECM.
Through our experiments, we treated nucleus pulposus cells—cells in the discs that often suffer from degeneration—with EPA. We observed that EPA not only boosted autophagy but also suppressed the harmful effects of ER stress, reducing cell death and limiting ECM degradation. Additionally, we utilized a rat model of IDD to see if these protective effects translated into a real-world setting. The findings indicated that EPA improved the health of the discs and effectively slowed down the progression of IDD in these rats.
In summary, this research highlights the potential of EPA as a therapeutic option for managing back pain related to disc degeneration. Our results suggest that EPA could play an important role in supporting the health of intervertebral discs and mitigating some of the common issues associated with chronic back pain.
Through our experiments, we treated nucleus pulposus cells—cells in the discs that often suffer from degeneration—with EPA. We observed that EPA not only boosted autophagy but also suppressed the harmful effects of ER stress, reducing cell death and limiting ECM degradation. Additionally, we utilized a rat model of IDD to see if these protective effects translated into a real-world setting. The findings indicated that EPA improved the health of the discs and effectively slowed down the progression of IDD in these rats.
In summary, this research highlights the potential of EPA as a therapeutic option for managing back pain related to disc degeneration. Our results suggest that EPA could play an important role in supporting the health of intervertebral discs and mitigating some of the common issues associated with chronic back pain.
Read More
9
We conducted a thorough investigation into how eicosapentaenoic acid (EPA) could relieve chronic low-back and knee pain in adults. The study was carefully structured as a randomized, double-blind, placebo-controlled trial, which helps ensure that the findings are reliable and unbiased.
Our participants, totaling 120 adults who had been suffering from pain in their low back and knees for at least three months, were divided into two groups. One group received a daily dose of 594 mg of l-serine combined with 149 mg of EPA, while the other group received a placebo. Over the course of eight weeks, we tracked their progress using various pain measurement tools.
The results were promising, showing that both l-serine and EPA together led to meaningful reductions in pain scores. This suggests that including EPA in treatment plans could be beneficial for those suffering from persistent low-back pain.
Our trial highlighted the importance of this combination in pain relief, particularly for chronic conditions. The findings from this study hold potential for guiding future treatments aimed at enhancing the quality of life for many suffering from chronic pain.
Our participants, totaling 120 adults who had been suffering from pain in their low back and knees for at least three months, were divided into two groups. One group received a daily dose of 594 mg of l-serine combined with 149 mg of EPA, while the other group received a placebo. Over the course of eight weeks, we tracked their progress using various pain measurement tools.
The results were promising, showing that both l-serine and EPA together led to meaningful reductions in pain scores. This suggests that including EPA in treatment plans could be beneficial for those suffering from persistent low-back pain.
Our trial highlighted the importance of this combination in pain relief, particularly for chronic conditions. The findings from this study hold potential for guiding future treatments aimed at enhancing the quality of life for many suffering from chronic pain.
Read More
9
We aimed to explore how eicosapentaenoic acid (EPA), an omega-3 fatty acid, can impact intervertebral disc degeneration, which is a common cause of lower back pain. In the study, we used Sprague Dawley rats that had their lumbar discs punctured to induce degeneration. After the surgery, the rats were split into two groups: one received a daily diet enriched with EPA and docosahexaenoic acid (DHA), while the other group followed a standard diet.
After a month of the omega-3 supplementation, we noticed a significant drop in specific blood markers indicating inflammation. By the end of the two-month period, advanced imaging techniques and tissue analysis revealed that the rats on the omega-3 diet had maintained better hydration and displayed less damage to their intervertebral discs compared to the control group.
These findings suggest that incorporating eicosapentaenoic acid into the diet could reduce the inflammation linked to disc degeneration, potentially offering a protective effect against the progression of back pain. This research opens pathways to exploring omega-3s as a viable treatment option for people suffering from chronic back issues.
After a month of the omega-3 supplementation, we noticed a significant drop in specific blood markers indicating inflammation. By the end of the two-month period, advanced imaging techniques and tissue analysis revealed that the rats on the omega-3 diet had maintained better hydration and displayed less damage to their intervertebral discs compared to the control group.
These findings suggest that incorporating eicosapentaenoic acid into the diet could reduce the inflammation linked to disc degeneration, potentially offering a protective effect against the progression of back pain. This research opens pathways to exploring omega-3s as a viable treatment option for people suffering from chronic back issues.
Read More
Most Useful Reviews
9
Reduced inflammation
3 people found this helpful
I have suffered from severe rheumatoid arthritis for over 40 years, with pain levels often between 6 and 10. My son suggested trying Sports Research brand omega-3 fish oil, which I commenced taking twice daily. Within a month, I noticed a considerable reduction in inflammation throughout my body, including my painfully swollen ankles. Thanks to this product, I hope to avoid returning to uncomfortable footwear meant to reduce swelling.
Read More
0
Stomach upset experience
Unfortunately, I didn’t find this one suitable. Despite the glowing reviews, it didn't agree with me. The packaging was impressive, and the capsules were clear and the right size. However, the suggested dosage caused significant stomach issues. The experience was worse than just having fish burps; it was rather unpleasant. I'll revert to algae-based omega supplements.
Read More
7.5
Joint pain relief
3 people found this helpful
I take four of these daily, and it profoundly impacts my joint pain. Attempting to reduce my intake brings back the discomfort, especially in my knees.
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 8 Researches
7.5
- All Researches
9
Eicosapentaenoic acid alleviates back pain
We explored how eicosapentaenoic acid (EPA) might help in treating intervertebral disc degeneration (IDD), a major contributor to back pain. Research highlights that this condition often involves endoplasmic reticulum (ER) stress and breakdown of the extracellular matrix (ECM), key processes that worsen IDD. Our investigation demonstrated that EPA can promote autophagy, a process that helps cells clean up and maintain balance within the ECM.
Through our experiments, we treated nucleus pulposus cells—cells in the discs that often suffer from degeneration—with EPA. We observed that EPA not only boosted autophagy but also suppressed the harmful effects of ER stress, reducing cell death and limiting ECM degradation. Additionally, we utilized a rat model of IDD to see if these protective effects translated into a real-world setting. The findings indicated that EPA improved the health of the discs and effectively slowed down the progression of IDD in these rats.
In summary, this research highlights the potential of EPA as a therapeutic option for managing back pain related to disc degeneration. Our results suggest that EPA could play an important role in supporting the health of intervertebral discs and mitigating some of the common issues associated with chronic back pain.
Through our experiments, we treated nucleus pulposus cells—cells in the discs that often suffer from degeneration—with EPA. We observed that EPA not only boosted autophagy but also suppressed the harmful effects of ER stress, reducing cell death and limiting ECM degradation. Additionally, we utilized a rat model of IDD to see if these protective effects translated into a real-world setting. The findings indicated that EPA improved the health of the discs and effectively slowed down the progression of IDD in these rats.
In summary, this research highlights the potential of EPA as a therapeutic option for managing back pain related to disc degeneration. Our results suggest that EPA could play an important role in supporting the health of intervertebral discs and mitigating some of the common issues associated with chronic back pain.
Read More
9
We conducted a thorough investigation into how eicosapentaenoic acid (EPA) could relieve chronic low-back and knee pain in adults. The study was carefully structured as a randomized, double-blind, placebo-controlled trial, which helps ensure that the findings are reliable and unbiased.
Our participants, totaling 120 adults who had been suffering from pain in their low back and knees for at least three months, were divided into two groups. One group received a daily dose of 594 mg of l-serine combined with 149 mg of EPA, while the other group received a placebo. Over the course of eight weeks, we tracked their progress using various pain measurement tools.
The results were promising, showing that both l-serine and EPA together led to meaningful reductions in pain scores. This suggests that including EPA in treatment plans could be beneficial for those suffering from persistent low-back pain.
Our trial highlighted the importance of this combination in pain relief, particularly for chronic conditions. The findings from this study hold potential for guiding future treatments aimed at enhancing the quality of life for many suffering from chronic pain.
Our participants, totaling 120 adults who had been suffering from pain in their low back and knees for at least three months, were divided into two groups. One group received a daily dose of 594 mg of l-serine combined with 149 mg of EPA, while the other group received a placebo. Over the course of eight weeks, we tracked their progress using various pain measurement tools.
The results were promising, showing that both l-serine and EPA together led to meaningful reductions in pain scores. This suggests that including EPA in treatment plans could be beneficial for those suffering from persistent low-back pain.
Our trial highlighted the importance of this combination in pain relief, particularly for chronic conditions. The findings from this study hold potential for guiding future treatments aimed at enhancing the quality of life for many suffering from chronic pain.
Read More
9
We aimed to explore how eicosapentaenoic acid (EPA), an omega-3 fatty acid, can impact intervertebral disc degeneration, which is a common cause of lower back pain. In the study, we used Sprague Dawley rats that had their lumbar discs punctured to induce degeneration. After the surgery, the rats were split into two groups: one received a daily diet enriched with EPA and docosahexaenoic acid (DHA), while the other group followed a standard diet.
After a month of the omega-3 supplementation, we noticed a significant drop in specific blood markers indicating inflammation. By the end of the two-month period, advanced imaging techniques and tissue analysis revealed that the rats on the omega-3 diet had maintained better hydration and displayed less damage to their intervertebral discs compared to the control group.
These findings suggest that incorporating eicosapentaenoic acid into the diet could reduce the inflammation linked to disc degeneration, potentially offering a protective effect against the progression of back pain. This research opens pathways to exploring omega-3s as a viable treatment option for people suffering from chronic back issues.
After a month of the omega-3 supplementation, we noticed a significant drop in specific blood markers indicating inflammation. By the end of the two-month period, advanced imaging techniques and tissue analysis revealed that the rats on the omega-3 diet had maintained better hydration and displayed less damage to their intervertebral discs compared to the control group.
These findings suggest that incorporating eicosapentaenoic acid into the diet could reduce the inflammation linked to disc degeneration, potentially offering a protective effect against the progression of back pain. This research opens pathways to exploring omega-3s as a viable treatment option for people suffering from chronic back issues.
Read More
8
We conducted a study to see if omega-3 fatty acids, specifically sourced from Clupeonella grimmi fish oil, could help alleviate back pain associated with dysmenorrhoea. Our research involved a cross-over trial with 36 young women aged 18-22 years.
Participants were split into two groups: one group took 15 mL of fish oil each day, while the other received a placebo. After three months, we switched their treatments.
The results were quite compelling. Women who took the fish oil reported a significant drop in their pain levels on the visual analogue scale, scoring an average of 20.9 compared to 61.8 for those on the placebo. We also noticed a remarkable reduction in both low back and abdominal pain.
Furthermore, the use of fish oil allowed participants to need fewer ibuprofen doses for pain relief, suggesting its effectiveness in managing menstrual-related discomfort. Overall, our findings indicate that eicosapentaenoic acid can play a positive role in easing back pain during menstruation.
Participants were split into two groups: one group took 15 mL of fish oil each day, while the other received a placebo. After three months, we switched their treatments.
The results were quite compelling. Women who took the fish oil reported a significant drop in their pain levels on the visual analogue scale, scoring an average of 20.9 compared to 61.8 for those on the placebo. We also noticed a remarkable reduction in both low back and abdominal pain.
Furthermore, the use of fish oil allowed participants to need fewer ibuprofen doses for pain relief, suggesting its effectiveness in managing menstrual-related discomfort. Overall, our findings indicate that eicosapentaenoic acid can play a positive role in easing back pain during menstruation.
Read More
8
We explored the connection between docosahexaenoic acid (DHA) and back pain. This study aimed to understand if higher levels of omega-3 fatty acids, like DHA, can lead to less frequent or intense back pain.
Using robust data from previous genome-wide association studies, we found that increased levels of circulating omega-3 fatty acids were linked to a lower risk of experiencing lower back pain and sciatica. This suggests that incorporating more omega-3 fatty acids in our diet could potentially help alleviate some of the discomfort associated with back pain.
Our analysis also pointed out that individuals with higher omega-3 levels experienced less abdominal and pelvic pain, alongside the benefits for back pain. It’s exciting to think about how simple dietary adjustments could contribute to managing chronic pain effectively.
Using robust data from previous genome-wide association studies, we found that increased levels of circulating omega-3 fatty acids were linked to a lower risk of experiencing lower back pain and sciatica. This suggests that incorporating more omega-3 fatty acids in our diet could potentially help alleviate some of the discomfort associated with back pain.
Our analysis also pointed out that individuals with higher omega-3 levels experienced less abdominal and pelvic pain, alongside the benefits for back pain. It’s exciting to think about how simple dietary adjustments could contribute to managing chronic pain effectively.
Read More
User Reviews
USERS' SCORE
Moderately Good
Based on 5 Reviews
7.6
- All Reviews
- Positive Reviews
- Negative Reviews
9
Reduced inflammation
3 people found this helpful
I have suffered from severe rheumatoid arthritis for over 40 years, with pain levels often between 6 and 10. My son suggested trying Sports Research brand omega-3 fish oil, which I commenced taking twice daily. Within a month, I noticed a considerable reduction in inflammation throughout my body, including my painfully swollen ankles. Thanks to this product, I hope to avoid returning to uncomfortable footwear meant to reduce swelling.
Read More
0
Stomach upset experience
Unfortunately, I didn’t find this one suitable. Despite the glowing reviews, it didn't agree with me. The packaging was impressive, and the capsules were clear and the right size. However, the suggested dosage caused significant stomach issues. The experience was worse than just having fish burps; it was rather unpleasant. I'll revert to algae-based omega supplements.
Read More
7.5
Joint pain relief
3 people found this helpful
I take four of these daily, and it profoundly impacts my joint pain. Attempting to reduce my intake brings back the discomfort, especially in my knees.
Read More
7.5
Eases neck tension
2 people found this helpful
Wow, 180 tablets is quite a lot! I struggled to find this due to stock issues; however, the shipping was fast. I experience significant tension in my neck which often leads to headaches, but since taking omega-3, I've found it to be effective. They are easy to swallow, despite their size.
Read More
2
No difference noted
I haven’t noticed a difference. I usually use California GOLD, but when it was out of stock, I tried this brand. Although it costs more, I still don't feel the difference. I will return to California GOLD.
Read More
Frequently Asked Questions
7.5
Eases neck tension
2 people found this helpful
Wow, 180 tablets is quite a lot! I struggled to find this due to stock issues; however, the shipping was fast. I experience significant tension in my neck which often leads to headaches, but since taking omega-3, I've found it to be effective. They are easy to swallow, despite their size.
2
No difference noted
I haven’t noticed a difference. I usually use California GOLD, but when it was out of stock, I tried this brand. Although it costs more, I still don't feel the difference. I will return to California GOLD.
0
Stomach upset experience
Unfortunately, I didn’t find this one suitable. Despite the glowing reviews, it didn't agree with me. The packaging was impressive, and the capsules were clear and the right size. However, the suggested dosage caused significant stomach issues. The experience was worse than just having fish burps; it was rather unpleasant. I'll revert to algae-based omega supplements.
9
Eicosapentaenoic acid alleviates back pain
We explored how eicosapentaenoic acid (EPA) might help in treating intervertebral disc degeneration (IDD), a major contributor to back pain. Research highlights that this condition often involves endoplasmic reticulum (ER) stress and breakdown of the extracellular matrix (ECM), key processes that worsen IDD. Our investigation demonstrated that EPA can promote autophagy, a process that helps cells clean up and maintain balance within the ECM.
Through our experiments, we treated nucleus pulposus cells—cells in the discs that often suffer from degeneration—with EPA. We observed that EPA not only boosted autophagy but also suppressed the harmful effects of ER stress, reducing cell death and limiting ECM degradation. Additionally, we utilized a rat model of IDD to see if these protective effects translated into a real-world setting. The findings indicated that EPA improved the health of the discs and effectively slowed down the progression of IDD in these rats.
In summary, this research highlights the potential of EPA as a therapeutic option for managing back pain related to disc degeneration. Our results suggest that EPA could play an important role in supporting the health of intervertebral discs and mitigating some of the common issues associated with chronic back pain.
Through our experiments, we treated nucleus pulposus cells—cells in the discs that often suffer from degeneration—with EPA. We observed that EPA not only boosted autophagy but also suppressed the harmful effects of ER stress, reducing cell death and limiting ECM degradation. Additionally, we utilized a rat model of IDD to see if these protective effects translated into a real-world setting. The findings indicated that EPA improved the health of the discs and effectively slowed down the progression of IDD in these rats.
In summary, this research highlights the potential of EPA as a therapeutic option for managing back pain related to disc degeneration. Our results suggest that EPA could play an important role in supporting the health of intervertebral discs and mitigating some of the common issues associated with chronic back pain.
9
We conducted a thorough investigation into how eicosapentaenoic acid (EPA) could relieve chronic low-back and knee pain in adults. The study was carefully structured as a randomized, double-blind, placebo-controlled trial, which helps ensure that the findings are reliable and unbiased.
Our participants, totaling 120 adults who had been suffering from pain in their low back and knees for at least three months, were divided into two groups. One group received a daily dose of 594 mg of l-serine combined with 149 mg of EPA, while the other group received a placebo. Over the course of eight weeks, we tracked their progress using various pain measurement tools.
The results were promising, showing that both l-serine and EPA together led to meaningful reductions in pain scores. This suggests that including EPA in treatment plans could be beneficial for those suffering from persistent low-back pain.
Our trial highlighted the importance of this combination in pain relief, particularly for chronic conditions. The findings from this study hold potential for guiding future treatments aimed at enhancing the quality of life for many suffering from chronic pain.
Our participants, totaling 120 adults who had been suffering from pain in their low back and knees for at least three months, were divided into two groups. One group received a daily dose of 594 mg of l-serine combined with 149 mg of EPA, while the other group received a placebo. Over the course of eight weeks, we tracked their progress using various pain measurement tools.
The results were promising, showing that both l-serine and EPA together led to meaningful reductions in pain scores. This suggests that including EPA in treatment plans could be beneficial for those suffering from persistent low-back pain.
Our trial highlighted the importance of this combination in pain relief, particularly for chronic conditions. The findings from this study hold potential for guiding future treatments aimed at enhancing the quality of life for many suffering from chronic pain.
8
We conducted a study to see if omega-3 fatty acids, specifically sourced from Clupeonella grimmi fish oil, could help alleviate back pain associated with dysmenorrhoea. Our research involved a cross-over trial with 36 young women aged 18-22 years.
Participants were split into two groups: one group took 15 mL of fish oil each day, while the other received a placebo. After three months, we switched their treatments.
The results were quite compelling. Women who took the fish oil reported a significant drop in their pain levels on the visual analogue scale, scoring an average of 20.9 compared to 61.8 for those on the placebo. We also noticed a remarkable reduction in both low back and abdominal pain.
Furthermore, the use of fish oil allowed participants to need fewer ibuprofen doses for pain relief, suggesting its effectiveness in managing menstrual-related discomfort. Overall, our findings indicate that eicosapentaenoic acid can play a positive role in easing back pain during menstruation.
Participants were split into two groups: one group took 15 mL of fish oil each day, while the other received a placebo. After three months, we switched their treatments.
The results were quite compelling. Women who took the fish oil reported a significant drop in their pain levels on the visual analogue scale, scoring an average of 20.9 compared to 61.8 for those on the placebo. We also noticed a remarkable reduction in both low back and abdominal pain.
Furthermore, the use of fish oil allowed participants to need fewer ibuprofen doses for pain relief, suggesting its effectiveness in managing menstrual-related discomfort. Overall, our findings indicate that eicosapentaenoic acid can play a positive role in easing back pain during menstruation.
References
- Sanders AE, Weatherspoon ED, Ehrmann BM, Soma PS, Shaikh SR, et al. Circulating Polyunsaturated Fatty Acids and Pain Intensity in Five Chronic Pain Conditions. J Pain. 2023;24:478. doi:10.1016/j.jpain.2022.10.008
- Lin Z, Ni L, Teng C, Zhang Z, Wu L, et al. Eicosapentaenoic Acid-Induced Autophagy Attenuates Intervertebral Disc Degeneration by Suppressing Endoplasmic Reticulum Stress, Extracellular Matrix Degradation, and Apoptosis. Front Cell Dev Biol. 2021;9:745621. doi:10.3389/fcell.2021.745621
- Sasahara I, Yamamoto A, Takeshita M, Suga Y, Suzuki K, et al. l-Serine and EPA Relieve Chronic Low-Back and Knee Pain in Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. J Nutr. 2020;150:2278. doi:10.1093/jn/nxaa156
- NaPier Z, Kanim LEA, Arabi Y, Salehi K, Sears B, et al. Omega-3 Fatty Acid Supplementation Reduces Intervertebral Disc Degeneration. Med Sci Monit. 2019;25:9531. doi:10.12659/MSM.918649
- Kawabata F, Tsuji T. Effects of dietary supplementation with a combination of fish oil, bilberry extract, and lutein on subjective symptoms of asthenopia in humans. Biomed Res. 2011;32:387.
- Moghadamnia AA, Mirhosseini N, Abadi MH, Omranirad A, Omidvar S. Effect of Clupeonella grimmi (anchovy/kilka) fish oil on dysmenorrhoea. East Mediterr Health J. 2010;16:408.
- Maroon JC, Bost JW. Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to nonsteroidal anti-inflammatory drugs for discogenic pain. Surg Neurol. 2006;65:326.
- Dai Y, Chen Y, Gu R, Zhang C, Jiang R. Causal association of polyunsaturated fatty acids with chronic pain: a two-sample Mendelian randomization study. Front Nutr. 2023;10:1265928. doi:10.3389/fnut.2023.1265928
